Early hCG addition to rFSH for ovarian stimulation in IVF provides better results and the cDNA copies of the hCG receptor may be an indicator of successful stimulation

Autor: Vana Sypsa, Peter Drakakis, Vasiliki Anastasiadou, Aris Antsaklis, Dimitris Loutradis, Erasmia Kiapekou, Antonis Makrigiannakis, Helen Arabatzi, George Kalofolias, D Paraskevis, Angelos Hatzakis, Konstantinos Stefanidis, Apostolos Beloukas
Jazyk: angličtina
Rok vydání: 2009
Předmět:
Adult
Infertility
medicine.medical_specialty
endocrine system
DNA
Complementary

Time Factors
lcsh:QH471-489
medicine.medical_treatment
Gene Dosage
Pilot Projects
Stimulation
Fertilization in Vitro
Biology
Chorionic Gonadotropin
lcsh:Gynecology and obstetrics
Drug Administration Schedule
Andrology
Follicle-stimulating hormone
Endocrinology
Ovulation Induction
Pregnancy
Internal medicine
medicine
Humans
lcsh:Reproduction
Lymphocytes
Receptor
reproductive and urinary physiology
lcsh:RG1-991
urogenital system
Research
Female infertility
Obstetrics and Gynecology
Receptors
LH

Prognosis
medicine.disease
Recombinant Proteins
Drug Combinations
Treatment Outcome
Reproductive Medicine
Female
Ovulation induction
Follicle Stimulating Hormone
Infertility
Female

hormones
hormone substitutes
and hormone antagonists

Developmental Biology
Hormone
Zdroj: Reproductive Biology and Endocrinology, Vol 7, Iss 1, p 110 (2009)
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY
Reproductive Biology and Endocrinology : RB&E
ISSN: 1477-7827
Popis: A simple, safe and cost-effective treatment protocol in ovarian stimulation is of great importance in IVF practice, especially in the case of previous unsuccessful attempts. hCG has been used as a substitute of LH because of the degree of homology between the two hormones. The main aim of this prospective randomized study was to determine, for the first time, whether low dose hCG added to rFSH for ovarian stimulation could produce better results compared to the addition of rLH in women entering IVF-ET, especially in those women that had previous IVF failures. An additional aim was to find an indicator that would allow us to follow-up ovarian stimulation and, possibly, modify it in order to achieve a better IVF outcome; and that indicator may be the cDNA copies of the LH/hCG receptor. Group A patients (n = 58) were administered hCG and Group B rLH (n = 56) in addition to rFSH in the first days of ovarian stimulation. The number of follicles and oocytes and, most importantly, implantation and pregnancy rates were shown to be statistically significantly higher in the hCG group. This study has also determined, for the first time to our best knowledge, m-RNA for LH/hCG receptors in the lymphocytes of peripheral blood 40 h before ovum pick-up. cDNA levels of the hCG receptor after ovarian stimulation were significantly higher among women receiving hCG compared to those receiving LH. In addition, higher levels were encountered among women with pregnancy compared to those without, although this was not statistically significant due to the small number of pregnancies. It seems that hCG permits a highly effective and more stable occupancy of rLH/hCG receptors and gives more follicles and more oocytes. The determination of cDNA copies could be, in the future, a marker during ovulation induction protocols and of course a predictor for the outcome of ART in the special subgroup of patients with previous failures.
Databáze: OpenAIRE